Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences CellTech 2013

CellTech 2013

Date: Tuesday, 22 January 2013 - Wednesday, 23 January 2013
Location: San Diego, CA, USA


Keynote Speakers

Matthew Croughan

Matthew Croughan
Professor and Director of the Amgen Bioprocessing Center at KGI, Kecks Graduate Institute

Mohamed Al-Rubeai

Mohamed Al-Rubeai
Director, University College Dublin

Stephen Minger

Stephen Minger
Global Director, GE Healthcare

Katharina Pachmann

Katharina Pachmann
Professor, University of Jena

Mario Roederer

Mario Roederer
Senior Investigator, National Institutes of Health

Karen Aboody

Karen Aboody
Associate Professor, City of Hope

Hans Keirstead

Hans Keirstead
Professor of Anatomy and Neurobiology, University of California, Irvine

Hakim Djaballah

Hakim Djaballah
CEO, Institute Pasteur - Korea

Ellen Feigal

Ellen Feigal
Senior Vice President, The California Institute for Regenerative Medicine

John Nolan

John Nolan
CEO, Cellarcus Biosciences, Inc.

Dario Marchetti

Dario Marchetti
Endowed Professor, Baylor College of Medicine

Paul Robinson

Paul Robinson
Professor of Biomedical Engineering, Purdue University Cytometry Laboratories

David Galbraith

David Galbraith
Professor, University of Arizona

Overview

Welcome to the inaugural CellTech2013 conference and exhibition. We have re-branded our Stem Cells World Congress / Circulating Tumor Cells / Cell Culture meeting for 2013 and expanded the scope of the event to include five conference tracks to enhance the overall experience of attendees.

Given the increasing interest in the analysis of cells in research, drug discovery and clinical applications, we are launching a 5-track conference bringing together all the key stakeholders in this space:

  • Cell-based Assays   
  • Flow Cytometry 
  • Cell Culture 
  • Circulating Tumor Cells (CTCs) 
  • Cancer & Stem Cells 

The Cell-based Assays and Flow Cytometry tracks will describe the research advances in, and the utility of, this class of assays for drug discovery, toxicity screening and drug development as well as methods for cell visualization. Cell Culture is focused on bioprocessing and bioproduction—given the interest in biologics and biosimilars, this is a must attend for companies seeking entry into this field. CTCs and CSCs represent the new frontier for cancer research, screening, biomarker development and patient monitoring in the future.  These two tracks will highlight research and clinical advances in these fields.


Corporate Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCellTech 2013CellTech 2013 in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com